Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Efficacy and Tolerability of Two Cough Syrups in Cough Due to Cold in Children.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* cough attributed to URTI such as the common cold~* 2-5 years of age~* moderate to severe day cough according to questionnaire (score at least 3 on all 3 questions relating to day cough) considering the day prior to enrollment.~* moderate to severe night cough score according to questionnaire (score at least 3 of 2 of the three questions relating to the evaluation of nocturnal cough (frequency of nocturnal cough, impact of the sleep of the child and impact on the sleep of the parent)~* signature of informed consent~Exclusion Criteria:~* Children with the diagnosis of diseases of the lower respiratory tract: inflammation of the larynx, trachea, bronchi, pneumonia, asthma, sinusitis, allergic rhinitis, as well as heart disease.~* Children who received cough medicines or drugs containing antihistamines the day prior to study entry.~* Known hypersensitivity to honey or any other component of the experimental product such as Grindelia, Helichrysum, essential oils natural flavourings of Lemon, Sweet Orange, Myrtle; Lemon natural flavouring~* Children who received any steroid preparation (spray nozzle , or syrup , or other similar the day before study entry )~* Known sensitivity to carbocysteine specifically to the comparator Mucolit~* gastric ulcer

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 5 Years
- Healthy Volunteers: f

Study Arms:
- protective cough syrup (Type: EXPERIMENTAL): syrup containing honey, plantago lanceolata, grindelia robusta, helichrysum italicum ina syrup form. The cough syrup is a CE marked medical device acting in a non pharmacological way to reduce cough.~Dosage: 20 ml divided in three doses per day for the duration of the study (4 nights, 3 days)
- carbocisteine cough syrup (Type: ACTIVE_COMPARATOR): Dosage 20-25 mg/kg/day three times a day (3 days/4 nights)

Based on this trial design, predict the completion outcome and termination type (if applicable).